Pharmacokinetics of the treatment of fungal infections.
D000475:Alkenes; D000666:Amphotericin B; D000818:Animals; D000935:Antifungal Agents / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D001230:Aspergillus; D001555:Benzene Derivatives; D002175:Candida; D003881:Dermatomycoses / Q000188:drug therapy; D005437:Flucytosine; D006118:Griseofulvin; D006801:Humans; D007093:Imidazoles; D007700:Kinetics; D051379:Mice; D008864:Microsporum; D009181:Mycoses / Q000188:drug therapy*; D010866:Natamycin; D009761:Nystatin; D014249:Trichophyton
D000475:Alkenes; D000935:Antifungal Agents; D001555:Benzene Derivatives; D007093:Imidazoles; D009761:Nystatin; D006118:Griseofulvin; D000666:Amphotericin B; D010866:Natamycin; D005437:Flucytosine